Clinical Trials on Hypertension, Renovascular in Switzerland

Total 303 results

EyeTechCare

Completed

Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)

Glaucoma

Spain, Israel, Italy, Switzerland
Kantonsspital Aarau

Unknown

aICP in Glaucoma and Papilledema (aICP Ophtha)

Open-angle Glaucoma | Papilledema

Switzerland
University of Basel

Completed

Sportcheck Follow-Up

Cardiovascular Diseases | Hypertension | Childhood Obesity

Switzerland
Novartis

Completed

Antiproteinuric Effect of Valsartan and Lisinopril

Hypertension | Diabetic Nephropathy

Switzerland
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

Hypertension

Switzerland
Meridian Bioscience, Inc.

Completed

Assessing Portal Hypertension With Methacetin Breath Test

Patients With Compensated Liver Cirrhosis

United States, France, Switzerland, Spain
Oertli Instrumente AG
University of Geneva, Switzerland

Unknown

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP (HFDS_abinterno)

Glaucoma | Cataract | POAG

Germany, Switzerland, Egypt, India
Hoffmann-La Roche

Recruiting

A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Neovascular Age-related Macular Degeneration (nAMD)

Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
Heike Bischoff-Ferrari

Recruiting

Electronic-Nutrition-Optimizer for Personalized Prevention (eNO)

Cardiovascular Diseases | Hypertension | Diabetes | Dementia | Frailty

Switzerland
Kantonsspital Aarau

Completed

non_invasive_aICP_Tumor (aICPTumor)

Intracranial Pressure Increase | Tumor, Brain

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration (FALCON)

Age-related Macular Degeneration

Germany, Switzerland
University of Zurich

Terminated

Hypertension Monitoring in Glioma Patients Treated With Bevacizumab

Glioma Patients

Switzerland
University of Basel

Completed

Exercise and Arterial Modulation in Youth (ExAMIN YOUTH)

Hypertension | Cardiovascular Disease | Childhood Obesity | Endothelial Dysfunction

Switzerland
Hoffmann-La Roche

Recruiting

Extension Study for the Port Delivery System With Ranibizumab (Portal) (Portal)

Neovascular Age-Related Macular Degeneration

Belgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
Novartis Pharmaceuticals

Terminated

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Switzerland, United States, Germany, Singapore, Korea, Republic of, Canada
University Hospital Inselspital, Berne

Recruiting

High Resolution Optical Coherence Tomography

Glaucoma | Macular Degeneration | Uveitis | Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Retinal Vein Occlusion | Optic Nerve Diseases | Retinal Detachment | Macular Disease | Retinal Disease | Retinal Neovascularization | Retinal Artery Occlusion | Hypertensive Retinopathy | Retinal Edema | Retinal Dystrophy

Switzerland
Novartis

Terminated

Antialbuminuric Effects of Valsartan and Lisinopril

Hypertension | Early Diabetic Nephropathy

Switzerland
Sleepiz AG

Completed

Sleepiz One+ Versus Capnography and Electrocardiography (SPZCAP)

Heart Diseases | Hypertension | Asthma | Sleep Apnea | COPD | Respiratory Disease

Switzerland
Nicole Ochsenbein
University of Zurich

Unknown

Pancreatic Stone Protein (PSP) in Pregnant Women

Pregnancy | Preeclampsia | HELLP Syndrome | Preterm Premature Rupture of Fetal Membranes

Switzerland
InnFocus Inc.

Completed

Post Market Study of the InnFocus MicroShunt

Primary Open Angle Glaucoma

France, Netherlands, Spain, Switzerland
Universitaire Ziekenhuizen KU Leuven
Allergan

Unknown

Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml (SPORTII)

Ocular Hypertension | Glaucoma

Belgium, Austria, Italy, Switzerland, United Kingdom
Novartis Pharmaceuticals

Terminated

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

Hypertension | Diabetic Nephropathy

Switzerland
University of Milan

Completed

Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures

Glaucoma

Germany, Greece, Italy, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients

Patients, Resistant Hypertension

Germany, Switzerland, United States, France, Netherlands, Denmark
Novartis

Completed

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Hypertension | Metabolic Syndrome

Germany, Switzerland
Medtronic Vascular

Completed

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) (HTN-2)

Uncontrolled Hypertension

Spain, Australia, Germany, France, Latvia, United Kingdom, Belgium, Austria, Poland, Switzerland
AGIR à Dom
University Hospital, Grenoble

Unknown

Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension (RAP)

Sleep Apnea | Hypertension, Resistant to Conventional Therapy

France, Canada, Switzerland
Clarunis - Universitäres Bauchzentrum Basel

Recruiting

Different Limb Lengths in Gastric Bypass Surgery (SLIM)

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias | Sleep Apnea | Obesity, Morbid

Switzerland
Novartis

Completed

An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

Hypertension

United States, Belgium, Denmark, Finland, Germany, Iceland, India, Switzerland
iSTAR Medical

Completed

STARflo European Safety and Efficacy Study

Open Angle Glaucoma

Belgium, Germany, Bulgaria, France, Switzerland
University of Paris 5 - Rene Descartes
University of Pecs; Charite University, Berlin, Germany; University of Zurich; University... and other collaborators

Unknown

Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis

Systemic Sclerosis | Pulmonary Hypertension

France, Germany, Hungary, Italy, Switzerland, United Kingdom
CVRx, Inc.

Completed

Device Based Therapy in Hypertension Trial (DEBuT-HT)

Hypertension

Netherlands, Switzerland, Czech Republic, Poland, Latvia, Germany
University of Zurich

Recruiting

Blood Loss and Preeclampsia

Blood Loss | Coagulation Disorder | Pre-Eclampsia; Complicating Pregnancy

Switzerland
Glaukos Corporation

Completed

A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

Open-Angle Glaucoma

Germany, Spain, Switzerland
Menno Pruijm

Recruiting

Nephrospec Switzerland

Hypertension | Chronic Kidney Diseases

Switzerland
Selim Orguel
University Hospital, Basel, Switzerland

Terminated

Obstructive Sleep Apnea Syndrome in Glaucoma

Obstructive Sleep Apnea Syndrome | Glaucoma

Switzerland
Novartis

Completed

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension (ACQUIRE)

Hypertension

Switzerland, Italy, Argentina, Germany, Turkey, United States, Ecuador, Guatemala
Novartis Pharmaceuticals

Completed

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD (SALT)

Neovascular Age-related Macular Degeneration

Germany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
Pfizer

Terminated

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

Hypertension, Pulmonary

Spain, United States, Canada, India, Germany, Russian Federation, Sweden, Switzerland
University Hospital, Basel, Switzerland
Swiss Tropical & Public Health Institute; Ifakara Health Institute

Completed

Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (RenalOne)

HIV Infections | Hypertension | Diabetes Mellitus | Chronic Kidney Diseases | Tuberculosis | Schistosomiasis

Switzerland
Actelion

Completed

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (MERIT-2)

Chronic Thromboembolic Pulmonary Hypertension

Poland, Ukraine, United Kingdom, China, Russian Federation, Belgium, Germany, Thailand, Hungary, France, Lithuania, Czechia, Mexico, Switzerland, Turkey
Bayer
Regeneron Pharmaceuticals

Active, not recruiting

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye (PULSAR)

Neovascular Age-Related Macular Degeneration

Spain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

Pulmonary Hypertension

United States, Netherlands, Canada, Spain, China, Belgium, Germany, Italy, United Kingdom, Switzerland, Australia, Austria, Czech Republic, France
Bayer

Completed

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension (EXPERT)

Hypertension, Pulmonary

Turkey, Austria, Czechia, Russian Federation, Slovakia, Switzerland, Italy, Germany, United Kingdom, France, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan, Denmark, Sweden, Argentina, Portugal, Saudi Arabia, Austral... and more
University of Zurich

Completed

Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)

Calciphylaxis | Hypertensive Ischemic Leg Ulcer

Switzerland
Actelion

Completed

Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (MERIT-1)

Chronic Thromboembolic Pulmonary Hypertension

United Kingdom, Belgium, Ukraine, Germany, Switzerland, Hungary, China, Korea, Republic of, Mexico, Czechia, France, Lithuania, Poland, Russian Federation, Thailand, Turkey
Novartis

Completed

Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension (ACCELERATE)

Hypertension

Switzerland, United Kingdom, Venezuela, France, South Africa, Greece, Canada, Costa Rica, Germany, Guatemala
Novartis

Completed

A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

Hypertension

United States, Belgium, Canada, Germany, Italy, Netherlands, Peru, Russian Federation, Switzerland, United Kingdom
International CTEPH Association

Completed

New International CTEPH Database

Chronic Thromboembolic Pulmonary Hypertension | CTEPH

Korea, Republic of, United States, Germany, Taiwan, Denmark, United Kingdom, Italy, Spain, Japan, Australia, Netherlands, Austria, Belgium, Brazil, Canada, Egypt, Finland, Poland, Russian Federation, Slovakia, Switzerland, Turkey
Actelion

Completed

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. (TRACE)

Pulmonary Arterial Hypertension

United States, United Kingdom, Ireland, Germany, Austria, France, Norway, Portugal, Sweden, Switzerland

Clinical Trials on Hypertension, Renovascular in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations